Tightening Health Care Belts, Without Feeling the Pinch
As it is right now, health care costs account for a shocking 17.6 percent of the United States’ GDP (gross domestic product), according to data from the Organization for Economic Co-operation and Development (OECD). The health care system is not just a money pit, but a time sink as well, with doctors spending three-quarters [...]
Risks of Untreated Hepatitis C
Guest Blog: Elvin Montanez, Pharm.D., Senior Vice President at BioPlus Specialty Pharmacy The U.S. Food and Drug Administration (FDA) recently added a boxed warning to some of the newer treatments for hepatitis C, warning patients to stop treatment if a systemic or progressive rash develops. Some media outlets treated this information as if it were completely [...]
Beyond the Boy in the Bubble
IgG therapy treats a wide variety of health conditions, including “Bubble Boy disease.” Bubble Boy disease refers to severe combined immune deficiency syndrome; the alliterative name was coined by the media after a boy who had lived in a plastic isolation ward in the 1970s. At the time, there were no treatments available, but today [...]
Technology Goals: Connecting Patients, Providers, and Payers
Therapy Access Portal – TAP AppA faster, easier, and more complete flow of information between health insurers and healthcare providers will result in more effective therapeutic outcomes for patients – and a better bottom line, notes the recent study “Advancing Healthcare Informatics: The Power of Partnerships” which was developed by the consulting company PricewaterhouseCoopers. Here [...]
Ig Replacement Therapy: Through the Eyes of a Parent and Patient Advocate
Guest Blog: Laurry Hinds, R.N., Regional Director for Business Development at BioPlus Specialty Pharmacy It was a cold day back in January of 2008 as I made my way to an appointment with my high-risk obstetrician for a scheduled Caesarian section. The gender of my baby would be a surprise I’d find out shortly, but what [...]